Tag Archives: hiv aids facts

HIV Prevention And HIV Vaccine

What is in the future for  HIV Vaccine?

Early advances in preventing HIV transmission resulted from educational programs describing how transmission occurs and providing barrier protection for those exposed to genital secretions and new needles or bleach to those exposed to blood by sharing needles. Despite these efforts, new infection in both the developed and developing worlds has continued at high rates.

Historically, the greatest success in preventing viral transmission has resulted from the development of preventative vaccines. Unfortunately, decades of research to develop an HIV vaccine has led to little hope for success. While the vaccine which has been developed demonstrated only limited evidence of protection, research is under way to further explore what can be learned for future vaccine development from this modest success. Continue reading

Side effects of HIV therapy:

There are many potential side effects associated with antiviral therapies. The most common ones for each class of drug are summarized below.

NRTIs

Most NRTIs can cause mild nausea and loose stools. In general, these symptoms resolve with time.

ZDV has been associated with decreased production of blood cells by the bone marrow, most often causing anemia, and occasionally hyperpigmentation (most often of the nails).

D4T can damage nerves and cause peripheral neuropathy, a neurological condition with numbness and/or tingling of the feet and hands, and inflammation of the pancreas (pancreatitis) that causes nausea, vomiting, and mid upper abdominal pain.

DDI also causes pancreatitis and, to a lesser extent, peripheral neuropathy. Peripheral neuropathy can become permanent and painful, and pancreatitis can be life-threatening if therapy is not discontinued. The drug ddC also is associated with peripheral neuropathy as well as oral ulcers. Continue reading

HIV Treatment Drugs

Initial therapy for HIV

Guidelines for using antiviral therapy have been developed and are updated on a regular basis by an expert panel assembled by the DHHS, the IAS-USA panel, and others. The DHHS guidelines are available at http://www.aidsinfo.nih.gov. The most recent IAS-USA guidelines were published in the Journal of the American Medical Association (JAMA) in the summer of 2010.

Antiviral treatment options have primarily included combinations of two nucleoside analogue reverse transcriptase inhibitors (NRTI), often referred to as “nucs,” and one PI, typically with a low dose of Ritonavir, a PI used at low doses to increase the level of the principle PI being used, so called “boosting.”

Alternative, options include the use of two NRTIs with a nonnucleoside analogue reverse transcriptase inhibitor (NNRTI), the latter often called “non-nucs.” These NNRTI-containing combinations generally are easier to take than PI-containing combinations and tend to have different side effects. Recently, NRTIs were combined with the integrase inhibitor raltegravir with very good viral suppression and tolerability. This novel combination has now been approved by the Food and Drug Administration as another treatment option for those initiating therapy for the first time and is considered along with NNRTIs and PIs as one of the preferred options. Continue reading

Students hold oil lamps beside a symbol of AIDS in Chennai

HIV Testing

How to diagnose HIV/AIDS?

HIV is most commonly diagnosed by testing blood or saliva for the presence of antibodies to the virus. These types of HIV tests aren’t accurate immediately after infection because body takes time to develop these antibodies — usually up to 12 weeks. In rare cases, it can take up to six months for an HIV antibody test to become positive.

A newer type of test checks for HIV antigen, a protein produced by the virus immediately after infection. This test can confirm a diagnosis within days of infection. An earlier  diagnosis help people to take extra precautions to prevent transmission of the virus to others.

Tests to start treatment:

If you receive a diagnosis of HIV/AIDS, several types of tests can help your doctor determine what stage of the disease you have. These tests include:

  • CD4 count. CD4 cells are a type of white blood cell that’s specifically targeted and destroyed by HIV. A healthy person’s CD4 count can vary from 500 to more than 1,000. Even if a person has no symptoms, HIV infection progresses to AIDS when his or her CD4 count becomes less than 200.
  • Viral load. This test measures the amount of virus in your blood. Studies have shown that people with higher viral loads generally have poor prognosis than do those with a lower viral load.
  • Drug resistance. This type of test determines if your strain of HIV is resistant to any anti-HIV medications. Continue reading
hiv-virus-and-hiv-symbol-thumb15767753

HIV AIDS Symptoms

What are symptoms and signs of HIV infection and AIDS?

The time from HIV infection to the development of full blown AIDS varies. Sometimes, individuals develop complications of HIV that define AIDS within one year, while others remain completely asymptomatic after as many as 20 years from the time of infection. However, in the absence of antiretroviral therapy the time for progression from initial infection to AIDS is approximately 8 to 10 years. The reason why people experience clinical progression of HIV at different rates remains an area of active research.

Within weeks of infection, many people will develop the varied symptoms of primary or acute infection which typically have been described as “influenza” like illness but can range from minimal fever, body aches, and pains to very severe symptoms. The most common initial symptoms of primary HIV infection are fever, aching muscles and joints ,sore throat, and swollen glands (lymph nodes) in the neck.

It is not known why only some HIV-infected people develop these symptoms. It also is unknown whether or not having the symptoms is related to the future course of AIDS disease. Nevertheless, infected people will become symptom-free after this phase of primary infection. During the first weeks of infection when a patient may have symptoms of primary HIV infection, antibody testing may still be negative, this is called window period. If there is suspicion of early infection based upon the types of symptoms present and a potential recent exposure, then a test is performed that specifically looks for the virus circulating in the blood, which is called a viral load test or the use of an assay that identifies HIV p24 antigen, for example, the new fourth-generation antibody/antigen combination test. Identifying and diagnosing individuals with primary infection at an early stage is important to assure early access into care and to counsel them regarding the risk of transmitting to others. The latter is particularly important since patients with primary HIV infection have very high levels of virus throughout their body and are likely to be highly infectious. Once the patient enters the asymptomatic phase, infected individuals will know whether or not they are infected if a test for HIV antibodies is done.

Shortly after primary infection, most individuals enter a period of many years where they have no symptoms at all. During this time, CD4 cells may gradually decline, and with this decline in the immune system, patients may develop the mild symptoms of HIV such as vaginal or oral candidiasis thrush (a fungal infection), fungal infections of the nails, a white brush-like border on the sides of tongue called hairy leukoplakia, chronic rashes, diarrhea, fatigue, and weight loss. With a further decline in function of the immune system, patients are at increasing risk of developing more severe complications of HIV, including many more serious infections (opportunistic infections), malignancies, severe weight loss, and decline in mental function. From a practical perspective, most physicians think about patients with HIV diseases as having no symptoms, mild symptoms, or being severely symptomatic. In addition, many would characterize a patient’s level of immunosuppression by the degree and type of symptoms they have as well as the CD4 cell count. The Centers for Disease Control and Prevention have defined the presence of a long list of specific diseases or the presence of less than 200 CD4 cells per mm3 as meeting a somewhat arbitrary definition of AIDS. With effective antiretroviral therapy many of the signs and symptoms of HIV as well as immunosuppression can be completely reversed, restoring even the most symptomatic patients to a state of excellent health.

Symptoms_of_acute_HIV_infection

Continue reading